UCB Pharma
UCB to Expand Epilepsy Portfolio With Strategic Acquisition of Midazolam Nasal Spray From Proximagen
FDI World Dental Federation
FDI white paper and practical guide address the global burden of periodontal disease
Grünenthal Group
Grünenthal and KU Leuven join forces to develop an innovative non-opioid pain treatment
Debiopharm International SA
Kaiku Health raises EUR4.4 million series A financing to accelerate its digital therapeutics pipeline led by Debiopharm and Tesi
Merck KGaA
Merck Receives Fast-Track Designation for Tepotinib in Non-Small Cell Lung Cancer in Japan
TiGenix and Takeda
TiGenix and Takeda Announce Alofisel® (darvadstrocel) Receives Approval to Treat Complex Perianal Fistulas in Crohn's Disease in Europe
Mallinckrodt Plc.
Mallinckrodt Announces First Investigator Award for Pioneering Efforts in ECP Immunomodulation
Novo Nordisk A/S
Semaglutide Injection Phase 2 Data Presented at ENDO Demonstrated Significant Weight Loss in Adults With Obesity
Kanabo Research
The Israeli Ministry of Health has Approved Kanabo Research's Medical Cannabis Vaporizer as a Medical Device
Campus Klinik an der Ruhr-Universität Bochum
Brain damage in newborns - unique index discovered / Head circumference determines brain damage in newborns!
Ein DokumentHitachi Medical Systems Europe Holding AG
Hitachi Medical Systems Europe announces "ScanSync" - a new function for diagnostic ultrasound that reduces the burden on operators - which is to be supported by the "ARIETTA Prologue"
InSightec
Israel Ministry of Health Includes INSIGHTEC's Focused Ultrasound Treatment for Medication-Refractory Essential Tremor as Part of Covered Health Services
Accuray
Accuray's European AERO Academy Meeting: Innovation and Safety in the Field of Advanced Radiotherapy - Patients Come First
Takeda Pharmaceutical Company Limited
Entyvio® (vedolizumab) Shows Higher Rates of Mucosal Healing Versus TNFalpha-Antagonist Therapy in Ulcerative Colitis and Crohn's Disease Patients in Comparative Effectiveness Real-World Data Analysis
Merck KGaA
Merck and Pfizer Provide Update on Phase III JAVELIN Lung 200 Trial of Avelumab Monotherapy in Previously Treated Patients with Advanced Non-Small Cell Lung Cancer
12345678910Nächste